<VariationArchive VariationID="830618" VariationName="NC_000007.14:g.(?_92509319)_(92509421_?)del" VariationType="Deletion" Accession="VCV000830618" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819924" VariationID="830618">
      <GeneList>
        <Gene Symbol="PEX1" FullName="peroxisomal biogenesis factor 1" GeneID="5189" HGNC_ID="HGNC:8850" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="92487025" stop="92528520" display_start="92487025" display_stop="92528520" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="92116336" stop="92157844" display_start="92116336" display_stop="92157844" Strand="-" />
          </Location>
          <OMIM>602136</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.14:g.(?_92509319)_(92509421_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="92138633" innerStop="92138735" display_start="92138633" display_stop="92138735" variantLength="103" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_92138633)_(92138735_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_92138633)_(92138735_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.14:g.(?_92509319)_(92509421_?)del AND Peroxisome biogenesis disorder 1A (Zellweger)" Accession="RCV001031237" Version="1">
        <ClassifiedConditionList TraitSetID="551">
          <ClassifiedCondition DB="MedGen" ID="C4721541">Peroxisome biogenesis disorder 1A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000007.14:g.(?_92509319)_(92509421_?)del AND Zellweger spectrum disorders" Accession="RCV001387289" Version="7">
        <ClassifiedConditionList TraitSetID="55427">
          <ClassifiedCondition DB="MedGen" ID="C0043459">Zellweger spectrum disorders</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-09" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11439091</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16086329</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16141001</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9398847</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="55427" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="52389" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Zellweger syndrome</ElementValue>
                <XRef ID="912" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum Disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger Spectrum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Zellweger spectrum disorders</ElementValue>
                <XRef ID="MONDO:0019609" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ZWS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ZS</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7917" />
                <XRef ID="7917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C0043459" DB="MedGen" />
              <XRef ID="MONDO:0019609" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="551" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5138" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 1a</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Zellweger leukodystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 1A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0008953" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CHR</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PBD1A</ElementValue>
                <XRef Type="MIM" ID="214100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger spectrum disorder (ZSD) is a phenotypic continuum ranging from severe to mild. While individual phenotypes (e.g., Zellweger syndrome [ZS], neonatal adrenoleukodystrophy [NALD], and infantile Refsum disease [IRD]) were described in the past before the biochemical and molecular bases of this spectrum were fully determined, the term "ZSD" is now used to refer to all individuals with a defect in one of the ZSD-PEX genes regardless of phenotype. Individuals with ZSD usually come to clinical attention in the newborn period or later in childhood. Affected newborns are hypotonic and feed poorly. They have distinctive facies, congenital malformations (neuronal migration defects associated with neonatal-onset seizures, renal cysts, and bony stippling [chondrodysplasia punctata] of the patella[e] and the long bones), and liver disease that can be severe. Infants with severe ZSD are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Individuals with intermediate/milder ZSD do not have congenital malformations, but rather progressive peroxisome dysfunction variably manifest as sensory loss (secondary to retinal dystrophy and sensorineural hearing loss), neurologic involvement (ataxia, polyneuropathy, and leukodystrophy), liver dysfunction, adrenal insufficiency, and renal oxalate stones. While hypotonia and developmental delays are typical, intellect can be normal. Some have osteopenia; almost all have ameleogenesis imperfecta in the secondary teeth.</Attribute>
                <XRef ID="NBK1448" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301621</ID>
                <ID Source="BookShelf">NBK1448</ID>
              </Citation>
              <XRef ID="C4721541" DB="MedGen" />
              <XRef ID="MONDO:0008953" DB="MONDO" />
              <XRef Type="MIM" ID="214100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2355797" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="7557147|MedGen:C0043459" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194543" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11439091</ID>
          </Citation>
          <Comment>This variant is an out-of-frame deletion of the genomic region encompassing exon 9 of the PEX1 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. Deletions of PEX1 exon 9 have been observed in individuals affected with peroxisomal biogenesis disorders (PMID: 11439091). Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_92138633)_(92138735_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Zellweger syndrome</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0043459" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3113522" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_000466.2_7_Deletion (exon 9)|MedGen:C0043459" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001587863" DateUpdated="2024-06-09" DateCreated="2021-05-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9398847</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16086329</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16141001</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11439091</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596). Deletions of PEX1 exon 9 have been observed in individuals affected with peroxisomal biogenesis disorders (PMID: 11439091). This variant is an out-of-frame deletion of the genomic region encompassing exon 9 of the PEX1 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_92138633)_(92138735_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043459" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2355797" TraitType="Disease" MappingType="Name" MappingValue="Zellweger syndrome" MappingRef="Preferred">
        <MedGen CUI="C0043459" Name="Zellweger spectrum disorders" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3113522" TraitType="Disease" MappingType="XRef" MappingValue="C0043459" MappingRef="MedGen">
        <MedGen CUI="C0043459" Name="Zellweger spectrum disorders" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

